European Companies Search Engine

14 wordmarks: BEZYNVI, EPZYNVO, EVIGUS, IPSYNVO, MARKLAS, NOILETCAPHARM, NUFLOZIA, OMLUENNE, OPAIRVI, OPZIPULM, PAHDUA, PERCUREX, TAVLEED, ZUXTANA BdlYear 2022 European Union Intellectual Property Office (Trade Marks)

Text

Actelion Pharmaceuticals Ltd., Allschwil, Switzerland

17/08/2022 Wordmark: “BEZYNVI“
17/08/2022 Wordmark: “EPZYNVO“
15/04/2022 Wordmark: “EVIGUS“
17/08/2022 Wordmark: “IPSYNVO“
28/07/2022 Wordmark: “MARKLAS“
28/07/2022 Wordmark: “NOILETCAPHARM“
15/04/2022 Wordmark: “NUFLOZIA“
17/08/2022 Wordmark: “OMLUENNE“
17/08/2022 Wordmark: “OPAIRVI“
17/08/2022 Wordmark: “OPZIPULM“
28/06/2022 Wordmark: “PAHDUA“
28/07/2022 Wordmark: “PERCUREX“
22/03/2022 Wordmark: “TAVLEED“
22/03/2022 Wordmark: “ZUXTANA“

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.

Creative Commons License The visualizations for "Actelion Pharmaceuticals Ltd. - 14 wordmarks: BEZYNVI, EPZYNVO, EVIGUS, IPSYNVO, MARKLAS, NOILETCAPHARM, NUFLOZIA, OMLUENNE, OPAIRVI, OPZIPULM, PAHDUA, PERCUREX, TAVLEED, ZUXTANA" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.